Palvella Therapeutics (NASDAQ: PVLA)
$22.08
(7.1%)
$1.46
Price as of June 27, 2025, 4:00 p.m. ET
Palvella Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Palvella Therapeutics Company Info
Develops and markets an anticalin-brand protein technology
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.